ロード中...
Enoxaparin 20 mg for thromboprophylaxis in severe renal impairment
OBJECTIVE: This study was performed to evaluate the efficacy of daily subcutaneous enoxaparin 20 mg in patients with renal failure. METHODS: This retrospective cohort study included nonsurgical patients aged ≥18 years with a creatinine clearance rate of <30 mL/minute who were prescribed enoxapari...
保存先:
| 出版年: | J Int Med Res |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6384464/ https://ncbi.nlm.nih.gov/pubmed/30259770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060518799896 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|